ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1263

Evidence for the Involvement of NK Cells in Antisynthetase Syndrome

Baptiste Hervier1, Yves Allenbach2, Mikael Perez3, Hervé Devilliers4, Fleur Cohen-Aubart5, Zahir Amoura6, Werner Stenzel7, Isabelle Cremer8, Olivier Benveniste2 and Vincent Vieillard1, 1INSERM UMR-S 1135, UPMC, Paris, France, 2UMR 974, Sorbonne Universités, University Pierre et Marie-Curie-Paris 6, INSERM, Paris, France, 3UMR-S 1138, INSERM & UPMC, Paris, France, 4CHU de Dijon, Dijon, France, 5Internal Medicine Dpt 2, Pitié-Salpêtrière Hospital, APHP, Paris, France, 6Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 7Department of Neuropathology, Charite Hospital, Berlin, Germany, 8INSERM UMR-S 1138, INSERM & UPMC, Paris, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Myositis

  • Tweet
  • Email
  • Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Myositis Autoantibodies and Disease Phenotype

Session Type: Abstract Submissions (ACR)

Background/Purpose Antisynthetase syndrome (aSS) is characterized by the association of interstitial lung disease and myositis with anti-tRNA-synthetase autoantibodies. Its pathogenesis remains unknown, especially regarding the involvement of innate immune cells, including natural killer (NK) cells. Here, we describe the first phenotypic and functional characterization of NK cells in this context.

Methods A total of 20 patients with inactive and active aSS were included (women/men =9, median age =50 years), and compared to 20 healthy controls. Freshly isolated NK cell phenotype was performed by Flow cytometry. Polyfunctionality assays were performed to measure degranulation and intracellular production of TNFa and IFNg, spontaneously or after stimulation by interleukin(IL)-12 and IL18, in the presence of K562 target cells. The presence and the localization of NK cells in primary human specimens of lung (n=3) and muscle (n=3) target tissue were studied by immunohistochemistry, using anti-NKp46 monoclonal antibody.

Results NK cells from inactive patients showed normal phenotype, whereas active aSS revealed a differentiated NK cell profile, as indicated by a increased level of CD57 (p=0.09) and ILT2 (p=0.016) associated with decreased CD161 (p=0.052) and NKp30 (p=0.009), compared to healthy donors. This is consistent with the inability of circulating NK cells of active aSS patients to produce IFNγ (p=0.0017) after IL12 plus IL18 stimulation, compared to healthy controls. More importantly, our in-depth analysis reveals that NKp30 down-modulation strongly correlated with the loss of NK cell functions (Spearman coefficient r=0.57, p=0.009), and could be a surrogate marker of aSS activity. Histological studies reveal for the first time the presence of small numbers of  NK cells in the muscles, as well as a massive infiltration of NK cells inside the lungs of aSS patients.

Conclusion Taken as a whole, NK cell phenotypic and polyfunctional changes as well as infiltration of target tissue argue for an involvement of NK cells in aSS pathogenesis.


Disclosure:

B. Hervier,
None;

Y. Allenbach,
None;

M. Perez,
None;

H. Devilliers,
None;

F. Cohen-Aubart,
None;

Z. Amoura,
None;

W. Stenzel,
None;

I. Cremer,
None;

O. Benveniste,
None;

V. Vieillard,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evidence-for-the-involvement-of-nk-cells-in-antisynthetase-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology